Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Medical Hypotheses
|
June 14, 2005
Does estradiol induced inhibition of 11beta-hydroxysteroid dehydrogenase 1 explain effects of the postmenopausal hormone replacement therapy?
Volker Bähr
Medizinische Klinik (Munich, Germany : 1983)
|
April 26, 2003
[Monogenic hypertension]
Volker Bähr, Wolfgang Oelkers, Sven Diederich
The American Journal of Clinical Nutrition
|
January 8, 2008
Is there a need for vitamin C supplementation of the normal diet? Effects of in vivo ascorbate depletion on adrenal function
Volker Bähr, Andreas F H Pfeiffer, Wolfgang Oelkers
European Journal of Endocrinology
|
May 30, 2003
Severe hyponatremia due to hypopituitarism with adrenal insufficiency: report on 28 cases
Sven Diederich, Norma-Fiona Franzen, Volker Bähr, et al.
European Journal of Endocrinology
|
November 30, 2006
Effect of exogenous glucocorticoid on osmotically stimulated antidiuretic hormone secretion and on water reabsorption in man
Volker Bähr, Norma Franzen, Wolfgang Oelkers, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
July 25, 2006
Vasopressin excess and hyponatremia: hydrocortisone treatment should be considered
Volker Bähr, Norma-Fiona Franzen, Andreas F H Pfeiffer, et al.
Clinical Endocrinology
|
August 14, 2012
Arginine vasopressin-dependent and AVP-independent mechanisms of renal fluid absorption during thirsting despite glucocorticoid-mediated vasopressin suppression
Friederike Ufer, Sven Diederich, Erling B Pedersen, et al.
Clinical Endocrinology
|
June 9, 2007
Rosiglitazone decreases 11beta-hydroxysteroid dehydrogenase type 1 in subcutaneous adipose tissue
Knut Mai, Janin Andres, Thomas Bobbert, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 6, 2002
11beta-hydroxysteroid dehydrogenase types 1 and 2: an important pharmacokinetic determinant for the activity of synthetic mineralo- and glucocorticoids
Sven Diederich, Ekkehard Eigendorff, Patrick Burkhardt, et al.
Archives of Physiology and Biochemistry
|
October 9, 2007
Cell-type specific regulation of the human 11beta-hydroxysteroid dehydrogenase type 1 promoter
Janin Andres, Knut Mai, Matthias Möhlig, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Medical Hypotheses
|
June 14, 2005
Does estradiol induced inhibition of 11beta-hydroxysteroid dehydrogenase 1 explain effects of the postmenopausal hormone replacement therapy?
Volker Bähr
Medizinische Klinik (Munich, Germany : 1983)
|
April 26, 2003
[Monogenic hypertension]
Volker Bähr, Wolfgang Oelkers, Sven Diederich
The American Journal of Clinical Nutrition
|
January 8, 2008
Is there a need for vitamin C supplementation of the normal diet? Effects of in vivo ascorbate depletion on adrenal function
Volker Bähr, Andreas F H Pfeiffer, Wolfgang Oelkers
European Journal of Endocrinology
|
May 30, 2003
Severe hyponatremia due to hypopituitarism with adrenal insufficiency: report on 28 cases
Sven Diederich, Norma-Fiona Franzen, Volker Bähr, et al.
European Journal of Endocrinology
|
November 30, 2006
Effect of exogenous glucocorticoid on osmotically stimulated antidiuretic hormone secretion and on water reabsorption in man
Volker Bähr, Norma Franzen, Wolfgang Oelkers, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
July 25, 2006
Vasopressin excess and hyponatremia: hydrocortisone treatment should be considered
Volker Bähr, Norma-Fiona Franzen, Andreas F H Pfeiffer, et al.
Clinical Endocrinology
|
August 14, 2012
Arginine vasopressin-dependent and AVP-independent mechanisms of renal fluid absorption during thirsting despite glucocorticoid-mediated vasopressin suppression
Friederike Ufer, Sven Diederich, Erling B Pedersen, et al.
Clinical Endocrinology
|
June 9, 2007
Rosiglitazone decreases 11beta-hydroxysteroid dehydrogenase type 1 in subcutaneous adipose tissue
Knut Mai, Janin Andres, Thomas Bobbert, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 6, 2002
11beta-hydroxysteroid dehydrogenase types 1 and 2: an important pharmacokinetic determinant for the activity of synthetic mineralo- and glucocorticoids
Sven Diederich, Ekkehard Eigendorff, Patrick Burkhardt, et al.
Archives of Physiology and Biochemistry
|
October 9, 2007
Cell-type specific regulation of the human 11beta-hydroxysteroid dehydrogenase type 1 promoter
Janin Andres, Knut Mai, Matthias Möhlig, et al.
Page
of 2